OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
336
Results
Show all
Save search
Copy query
Show results for
Unknown
(329)
Transcriptomics
(4)
Proteomics
(3)
Organisms
Homo sapiens
(4)
Mus musculus
(3)
Repository
biostudies-arrayexpress
(4)
pride
(3)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Femur
(1)
HEK-293T cell
(1)
Macrophage
(1)
Tibia
(1)
Technology Type
Mass Spectrometry
(3)
Data-independent acquisition
(2)
Affinity purification coupled with mass spectrometry proteomics
(1)
Bottom-up proteomics
(1)
Shotgun proteomics
(1)
Publication Date
2015
(1)
2014
(1)
2013
(1)
2012
(1)
2025
(1)
2024
(1)
2023
(1)
Study type
Transcription profiling by array
(2)
RNA-seq of coding RNA
(1)
RNA-seq of non coding RNA
(1)
Release Date
2023
(37)
2021
(37)
2020
(35)
2022
(33)
2019
(33)
2025
(30)
2024
(26)
2018
(24)
2016
(17)
2015
(12)
2026
(10)
2017
(10)
2013
(8)
2014
(6)
2011
(4)
2012
(3)
2010
(2)
2008
(1)
2007
(1)
2005
(1)
2002
(1)
2001
(1)
2000
(1)
Lab affiliation
Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany
(1)
Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, Freiburg 79104, Germany CIBSS - Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg 79104, Germany
(1)
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Am Klinikum1, 07747 Jena, Germany
(1)
Previous
page
1 / 34
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
34
Next
page
Sort
by:
Relevance
Page size
10
Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study.
Not available
S-EPMC6242015
|
biostudies-literature
Cite
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study.
Not available
S-EPMC6540397
|
biostudies-literature
Cite
A Novel Method for Identifying a Parsimonious and Accurate Predictive Model for Multiple Clinical Outcomes.
Not available
S-EPMC8098121
|
biostudies-literature
Cite
Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
Not available
S-EPMC5012662
|
biostudies-literature
Cite
Identifying barriers and facilitators in HIV-indicator reporting for different health facility performances: A qualitative case study.
Not available
S-EPMC7906392
|
biostudies-literature
Cite
A Systematic Review Investigating Associations Between E-Cigarette Use Among Former Cigarette Smokers and Relapse to Smoking Cigarettes.
Not available
S-EPMC10687958
|
biostudies-literature
Cite
A one-year hospital system review of plasma next-generation sequencing in a mixed population.
Not available
S-EPMC11574590
|
biostudies-literature
Cite
A multivariate statistical evaluation of actual use of electronic health record systems implementations in Kenya.
Not available
S-EPMC8423313
|
biostudies-literature
Cite
Paternal mosaicism for a novel PBX1 mutation associated with recurrent perinatal death: Phenotypic expansion of the PBX1-related syndrome.
Not available
S-EPMC7217179
|
biostudies-literature
Cite
NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells.
Not available
S-EPMC7398170
|
biostudies-literature
Cite
Previous
page
1 / 34
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
34
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
